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THE INHIBITION OF LIPEMIA-CLEARING
BY HYPERLIPEMIC SERUM *
WALTER F. LEVER, M.D. AND EDMUND KLEIN, M.D.
It was recently shown in this laboratory (1) that in idiopathic hyperlipemia
the elimination of lipids from the blood stream following an intravenous infusion
of a fat emulsion is considerably delayed, indicating a defect of the lipemia-
clearing mechanism in these patients.
It was then found that the clearing activity present in the serum of normal hu-
man subjects who have received heparin was inhibited by the serum of patients
with primary or secondary hyperlipemia (2). It was suggested that this inhibi-
tion of clearing was the cause of the hyperlipemia.
Seifter and Baeder (3) have shown that an inhibitor of lipemia clearing is
present in the serum of rats with experimental nephrosis and those receiving
cortisone. In addition they demonstrated the presence of an inhibitor of lipemia
clearing in the serum of normal rats, although its concentration was much
lower than in rats receiving cortisone. Crum, I lein and Lever (4) have sepa-
rated dialyzable and nondialyzable inhibitors of lipemia clearing from normal
bovine serum (5). Hollett and Meng (6) have recently described the presence
of an inhibitor of lipemia clearing in normal human blood.
MATERIALS AND METHODS
The sera of 5 patients with idiopathic hyperlipeniia (hyperlipemic sera) and of 5 normal
human subjects (normal sera) were studied. The patients as well as control subjects had
been fasting for 12 hours preceding the removal of blood for these tests. Clearing factor
containing serum (active serum) was obtained from normal human subjects 15 minutes
after they had received heparint intravenously in a dosage of .75 mg./kg. of body weight.
The serum was either used or frozen immediately after separation, since it had been noted
that the clearing activity of post-heparin serum decreased quite rapidly at room tempera-
ture. On incubation at 38° C. the loss of clearing activity was even greater and amounted
to 00 per cent over an 8 hour period.
The following methods were used for the experiments reported here:
1. In order to compare quantitatively the effects of normal and of hyperlipemic sera on
the clearing activity of active serum, varying amounts of either normal serum or hyper-
lipemic serum were mixed with active serum, the final volume being kept constant at 1.2 cc.
Then 0.3 cc. of a standard fat emulsion was added to the mixtures and the optical den-
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sity changes were determined spectrophotometrically at intervals of 10 minutes as de-
scribed by Grossman (7).
2. In order to determine whether the inhibitory activity was associated with the serum
lipids, the sera of patients with idiopathic hyperlipemia obtained both before and after
the intravenous administration of 100 mg. of heparin were centrifuged at 32,000 g for 30
minutes at 4° C. The sera of normal control subjects in a state of alimentary lipemia (in-
duced by the ingestion of 200 cc. of 10 per cent cream 4 hours prior to drawing the blood
sample) were similarly centrifuged. The supernatant lipid fraction was separated from the
clear infranatant Fraction (F-Il). The supernatant lipid fraction was diluted with 4 volumes
of normal serum (F-I). Aliquots of 0.6 cc. F-I or F-Il were added to 0.6 cc. of active serum
and 0.3 cc. of standard fat emulsion were added to the mixture. The optical density changes
were determined as described above (7).
RESULTS
1. Reduction of clearing activity in active serum by normal and hyperlipemic
sera (Fig. 1). Gradual dilution of active serum with normal serum did not
result in any reduction of clearing activity until the mixture consisted of equal
parts of active serum and normal serum. Almost 50 per cent of the original
clearing activity was still present when the mixture contained only 1 part of
active serum to 9 parts of normal serum. On further dilution with normal serum
the rate of clearing decreased rapidly.
The rate of reduction of clearing activity was considerably greater on dilu-
tion with hyperlipemic serum than with normal serum. Addition of 1 part of
400
FIG. 1. Changes in clearing activity (i.e., decrease in optical density,—OD) in serum
containing clearing activity on gradual dilution with normal serum and with serum of
patients with idiopathic hyperlipemia, respectively. On dilution with normal serum no
significant reduction of clearing activity occurs at first. After dilution to less than 10 per
cent a rapid decrease in clearing activity takes place. Dilution with hyperlipemic serum,
on the other hand, leads to initial rapid decrease in clearing activity.
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TABLE I
Effects of intravenously administered heparin on the localization of the anticlearing activity
in serum of patients with idiopathic hyperlipemia
Test Material° Initial O.D. Change in O.D.
0.6 cc. N.S 0.68 0.21 0.47
0.6 cc. U.S. (pre-heparin) 0.85 0.78 0.07
/ (0.48 cc. N.S.
(0.12 cc. top layert of U.S. (pre-heparin)J 0 83. 0 79. 0 04.
0.6 cc. infranatant of U.S. (pre-heparin) 0.67 0.23 0.44
0.6 cc. U.S. (post-heparin) 0.87 0.81 0.06
5(0.48 cc. N.S.
1(0.12 cc. top layert of U.S. (post-heparin) 0 85. 0 42• 0 43
0.6 cc. infranatant of U.S. (post-heparin) 0.70 0.68 0.02
0.6 cc. alimentary lipemic serum 0.88 0.41 0.47
* The clearing system contained 0.6 cc. active serum, 0.3 cc. standard fat emulsion and
0.6 cc. of the material tested. (N.S. — normal serum; U.S. = hyperlipemic serum).
t Lipid-containing layer obtained by centrifugation of serum at 32,000 g for 30 minutes
at 4°C.
1 Obtained after centrifugation of serum at 32,000 g for 30 minutes at 4° C.
hyperlipemic serum to 9 parts of active serum caused a 20—30 per cent reduction
of clearing activity. When active and hyperlipemic sera were mixed in equal
proportions the clearing activity of the active serum was reduced by 60—95 per
cent. As the concentration of hyperlipemic serum was increased further no
clearing occurred.
2. Association of clearing inhibition with serum lipids (Table I). The lipid
layer obtained by high speed centrifugation of the fasting serum of 4 patients
with idiopathic hyperlipemia, contained all the inhibitory activity, while the
clear infranatant layer contained none. When the serum of these patients was
tested after they had received heparin intravenously, it was found that the inhibi-
tion had shifted to the infranatant layer and that the supranatant layer con-
tained the heparin-induced clearing activity. Neither the lipid fraction nor the
infranatant fraction of the serum of normal subjects with alimentary hyper-
lipemia had any inhibitory effect on the clearing activity.
DISCUSSION
The clearing activity of active serum on gradual dilution with normal serum
was not significantly affected until a 10-fold dilution was reached. Thus there
is no stoichiometric relation between the diluent (normal serum) and the agent
producing clearing. This suggests that lipemia-clearing is due to an enzymatic
activity in the serum. Other explanations appear unlikely since the concentra-
tion of essential factors of the clearing system other than heparin-induced
clearing factor have not been altered by the addition of normal serum. The
lipemia-clearing activity in the serum may be analogous to the lipoprotein
lipase of tissues (tissue clearing factor) previously described by Korn (8). The
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decrease of clearing activity upon gradual dilution with hyperlipemic serum
was rapid, indicating that hyperlipemic serum exerts a strongly inhibitory effect
on lipemia-clearing.
It should be pointed out that according to the findings of Hollett and Meng
(6) some inhibitory activity is present in normal human serum. The data pre-
sented here, however, indicate that the concentration of inhibitor in hyper-
lipemic serum greatly exceeds that present in normal serum.
The observation that in hyperlipemic serum the inhibition of clearing activity
is present in the supernatant lipid fraction before the intravenous administration
of heparin while afterwards the inhibition is present in the infranatant fraction
and clearing activity in the supranatant fraction, suggests that the heparin-
induced clearing factor displaces an inhibitor from the supernatant lipid fraction.
This may be due to the fact that the heparin-induced clearing factor becomes
associated with the serum lipids. Evidence for this assumption is our recent
observation that on continuous paper electrophoresis of active serum, over 80
per cent of the clearing activity is present in the alpha- and beta-lipoprotein
fractions (9).
SUMMARY AND CONCLUSIONS
1. Gradual dilution of clearing activity containing serum (in vivo hepari-
nized "active serum") with normal fasting serum caused no significant reduction
of clearing activity until the concentrations of the active serum was reduced
to 50 per cent. After dilution to less than 10 per cent clearing activity decreased
rapidly. On the other hand, gradual dilution of active serum with serum from
patients with idiopathic hyperlipemia resulted in a rapid initial decrease in
clearing activity.
2. The slow initial decrease in clearing activity on addition of normal serum
suggests that lipemia clearing in active serum is due to an enzymatic activity.
The rapid decrease in clearing activity on addition of serum from patients
with idiopathic hyperlipemia indicates that such serum strongly inhibits lipe-
mia clearing.
3. The inhibitory activity present in the serum of patients with idiopathic
hyperlipemia was localized in the supernatant lipid fraction after centrifugation
of the serum in the fasting state. After intravenous administration of heparin the
inhibitory activity was located in the clear infranatant fraction.
4. The shift in the localization of the inhibition after the administration of
heparin occurred at the same time as the heparin-induced clearing factor became
associated with the supernatant lipid fraction. It is possible, therefore, that the
heparin-induced clearing factor displaces the inhibitor from the serum lipids of
the supernatant layer.
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